Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Novel Method for Highly Efficient Ex Vivo Expansion and Genetic Engineering of Human Natural Killer Cells for Cancer Therapy

Nobuhiro Kubo, Yudai Murayama, Yasushi Kasahara, Chansu Shin, Minori Baba, Ryosuke Hosokai, Haruko Iwabuchi, Imamura Masaru, Akihiko Saitoh, Chihaya Imai

Blood (2021) 138 (Supplement 1): 2850.

https://doi.org/10.1182/blood-2021-152356

Published: 2021

Journal Articles

A Novel NKp44-Based Chimeric Antigen Receptor That Targets Multiple Types of Cancer

Yasushi Kasahara, MD, Changsu Shin, MD, Sakiko Yoshida, MD PhD, Takayuki Takachi, MD PhD, Nobuhiro Kubo, MD, Haruko Iwabuchi, MD PhD, Masaru Imamura, MD PhD, Akihiko Saitoh, MD PhD, Chihaya Imai, MD PhD

Blood (2016) 128 (22): 3517.

https://doi.org/10.1182/blood.V128.22.3517.3517

Published: 2016

Journal Articles

Interleukin-21 Gene Transduction in Human Natural Killer Cells Enhances Their Anti-Leukemic Capacity

Yasushi Kasahara, MD, Changsu Shin, MD, Takayuki Takachi, MD PhD, Haruko Iwabuchi, MD PhD, Masaru Imamura, MD PhD, Akihiko Saitoh, MD PhD, Chihaya Imai, MD PhD

Blood (2015) 126 (23): 5425.

https://doi.org/10.1182/blood.V126.23.5425.5425

Published: 2015

Journal Articles

Patients’ Peripheral Blood as a Possible Source of Donor-Derived NK Cells for Ex Vivo Expansion and Genetic Modification for Post-Transplant Cellular Immunotherapy In Cord Blood Recipients

Chihaya Imai, MD, PhD, Sakiko Yoshida, MD, PhD, Takayuki Takachi, MD, Masaru Imamura, MD, PhD, Ryosuke Hosokai, MD, Haruko Iwabuchi, MD, PhD, Makoto Uchiyama, MD, Keiko Asami, MD, Atsushi Ogawa, MD, Akihiro Watanabe, MD

Blood (2010) 116 (21): 2094.

https://doi.org/10.1182/blood.V116.21.2094.2094

Published: 2010

Journal Articles

Interleukin-2 Gene Transduction in Human Natural Killer Cells Augments Their Survival and Anti-Leukemic Capacity

Chihaya Imai, MD, PhD, Takayuki Takachi, MD, Haruko Iwabuchi, MD, PhD, Masaru Imamura, MD, PhD, Tae Nemoto, MD, Dario Campana, MD, PhD, Makoto Uchiyama, MD, PhD

Blood (2008) 112 (11): 5437.

https://doi.org/10.1182/blood.V112.11.5437.5437

Published: 2008

NARROW

A Novel Method for Highly Efficient Ex Vivo Expansion and Genetic Engineering of Human Natural Killer Cells for Cancer Therapy

A Novel NKp44-Based Chimeric Antigen Receptor That Targets Multiple Types of Cancer

Interleukin-21 Gene Transduction in Human Natural Killer Cells Enhances Their Anti-Leukemic Capacity

Patients’ Peripheral Blood as a Possible Source of Donor-Derived NK Cells for Ex Vivo Expansion and Genetic Modification for Post-Transplant Cellular Immunotherapy In Cord Blood Recipients

Interleukin-2 Gene Transduction in Human Natural Killer Cells Augments Their Survival and Anti-Leukemic Capacity

Email alerts

ASH Publications

American Society of Hematology

A Novel Method for Highly Efficient Ex Vivo Expansion and Genetic Engineering of Human Natural Killer Cells for Cancer Therapy

A Novel NKp44-Based Chimeric Antigen Receptor That Targets Multiple Types of Cancer

Interleukin-21 Gene Transduction in Human Natural Killer Cells Enhances Their Anti-Leukemic Capacity

Patients’ Peripheral Blood as a Possible Source of Donor-Derived NK Cells for Ex Vivo Expansion and Genetic Modification for Post-Transplant Cellular Immunotherapy In Cord Blood Recipients

Interleukin-2 Gene Transduction in Human Natural Killer Cells Augments Their Survival and Anti-Leukemic Capacity

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only